The Asian Fund for Cancer Research is pleased to announce Chimera Bioengineering as the Winner of the 2021 BRACE Award Venture Competition. The start-up company is developing an innovative CAR-T cell therapeutic technology platform targeting solid tumors. After being chosen among six semi-finalists in the 17 September 2021 BRACE Award Venture Competition, and following extensive due diligence, Chimera Bioengineering has received US$500,000 in equity investment from AFCR. The new funding allows the company, whose technology and team are addressing cancers prevalent in Asian populations, to pursue proof of concept and proof of value on the path to clinical trials and, eventually, to new effective therapeutics that could save patients’ lives.
In addition, Believer Inc. was selected as the Second Place Winner by the BRACE Award Venture Competition Judging Committee, and KYAN Therapeutics has been named Best Public Communicator as the result of earning the most online votes by viewers of its program application video. Watch the videos below and learn more about these and the other risk-taking, early stage cancer technology companies who advanced as 2021 BRACE Award Venture Competition semi-finalists. Each is based in Asia or battling cancers prevalent in our region or among Asian populations!
Ready to do more? DONATE NOW and help us double the impact for early-stage oncology start-ups that are creating life-saving innovations!
WINNER
Gus Zeiner, Ph.D.
Co-Founder
Second Place Winner
Bee Hui Liu, Ph.D.
Co-Founder
Best Public Communicator
Edward Kai-Hua Chow, Ph.D.
Co-Founder
Other Semi-Finalists
Lynda Chin, M.D.
Chief Executive Officer
Huren Sivaraj, M.D.
Co-Founder & Chief Executive Officer
Chuanhua (Julia) Xing, Ph.D.
Chief Executive Officer
Supporters & Sponsors
Vote submission e-mail addresses will be added to the Asian Fund for Cancer Research’s general communication recipient list. These e-mail addresses will NEVER be sold, rented or otherwise conveyed to any other organization except only the National Foundation for Cancer Research and AIM-HI Accelerator Fund, both of which are BRACE Award Venture Competition sponsors—and they themselves will NEVER sell, rent or otherwise convey the e-mail addresses to any other organization, without exception.
